vs
Side-by-side financial comparison of Athene Holding Ltd. (ATHS) and GE HealthCare (GEHC). Click either name above to swap in a different company.
Athene Holding Ltd. is the larger business by last-quarter revenue ($8.1B vs $5.7B, roughly 1.4× GE HealthCare). GE HealthCare runs the higher net margin — 10.3% vs 6.4%, a 3.9% gap on every dollar of revenue. On growth, Athene Holding Ltd. posted the faster year-over-year revenue change (115.1% vs 7.1%). Over the past eight quarters, Athene Holding Ltd.'s revenue compounded faster (19.2% CAGR vs 10.7%).
Athene Holding Ltd. is a leading US-focused retirement services provider. It offers fixed, indexed and variable annuity products plus tailored retirement savings solutions for individual consumers and institutional clients, aiming to help customers secure long-term financial stability for their retirement.
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures...
ATHS vs GEHC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $8.1B | $5.7B |
| Net Profit | $523.0M | $588.0M |
| Gross Margin | — | 39.7% |
| Operating Margin | 16.9% | 14.5% |
| Net Margin | 6.4% | 10.3% |
| Revenue YoY | 115.1% | 7.1% |
| Net Profit YoY | -48.5% | -18.4% |
| EPS (diluted) | — | $1.28 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $8.1B | $5.7B | ||
| Q3 25 | $8.0B | $5.1B | ||
| Q2 25 | $5.4B | $5.0B | ||
| Q1 25 | $4.2B | $4.8B | ||
| Q4 24 | $3.8B | $5.3B | ||
| Q3 24 | $6.5B | $4.9B | ||
| Q2 24 | $4.7B | $4.8B | ||
| Q1 24 | $5.7B | $4.7B |
| Q4 25 | $523.0M | $588.0M | ||
| Q3 25 | $1.3B | $446.0M | ||
| Q2 25 | $464.0M | $486.0M | ||
| Q1 25 | $465.0M | $564.0M | ||
| Q4 24 | $1.0B | $721.0M | ||
| Q3 24 | $625.0M | $470.0M | ||
| Q2 24 | $629.0M | $428.0M | ||
| Q1 24 | $1.2B | $374.0M |
| Q4 25 | — | 39.7% | ||
| Q3 25 | — | 38.7% | ||
| Q2 25 | — | 39.6% | ||
| Q1 25 | — | 42.1% | ||
| Q4 24 | — | 42.8% | ||
| Q3 24 | — | 41.7% | ||
| Q2 24 | — | 41.4% | ||
| Q1 24 | — | 40.9% |
| Q4 25 | 16.9% | 14.5% | ||
| Q3 25 | 26.8% | 12.7% | ||
| Q2 25 | 12.2% | 13.1% | ||
| Q1 25 | 22.3% | 13.2% | ||
| Q4 24 | 30.4% | 15.1% | ||
| Q3 24 | 25.7% | 13.9% | ||
| Q2 24 | 22.0% | 12.6% | ||
| Q1 24 | 31.1% | 11.6% |
| Q4 25 | 6.4% | 10.3% | ||
| Q3 25 | 15.7% | 8.7% | ||
| Q2 25 | 8.7% | 9.7% | ||
| Q1 25 | 11.1% | 11.8% | ||
| Q4 24 | 26.8% | 13.6% | ||
| Q3 24 | 9.6% | 9.7% | ||
| Q2 24 | 13.5% | 8.8% | ||
| Q1 24 | 20.8% | 8.0% |
| Q4 25 | — | $1.28 | ||
| Q3 25 | — | $0.98 | ||
| Q2 25 | — | $1.06 | ||
| Q1 25 | — | $1.23 | ||
| Q4 24 | — | $1.58 | ||
| Q3 24 | — | $1.02 | ||
| Q2 24 | — | $0.93 | ||
| Q1 24 | — | $0.81 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $4.5B |
| Total DebtLower is stronger | $7.8B | $10.0B |
| Stockholders' EquityBook value | $20.5B | $10.4B |
| Total Assets | $442.2B | $36.9B |
| Debt / EquityLower = less leverage | 0.38× | 0.96× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $4.5B | ||
| Q3 25 | — | $4.0B | ||
| Q2 25 | — | $3.7B | ||
| Q1 25 | — | $2.5B | ||
| Q4 24 | — | $2.9B | ||
| Q3 24 | — | $3.5B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | $15.3B | $2.6B |
| Q4 25 | $7.8B | $10.0B | ||
| Q3 25 | $7.9B | $10.3B | ||
| Q2 25 | $7.9B | $10.3B | ||
| Q1 25 | $6.3B | $8.8B | ||
| Q4 24 | $6.3B | $9.0B | ||
| Q3 24 | $5.7B | $10.3B | ||
| Q2 24 | $5.7B | $9.2B | ||
| Q1 24 | $5.7B | $9.3B |
| Q4 25 | $20.5B | $10.4B | ||
| Q3 25 | $20.4B | $10.0B | ||
| Q2 25 | $18.1B | $9.7B | ||
| Q1 25 | $17.5B | $9.2B | ||
| Q4 24 | $16.4B | $8.4B | ||
| Q3 24 | $17.4B | $8.3B | ||
| Q2 24 | $15.0B | $7.8B | ||
| Q1 24 | $14.8B | $7.4B |
| Q4 25 | $442.2B | $36.9B | ||
| Q3 25 | $429.9B | $36.1B | ||
| Q2 25 | $405.3B | $35.5B | ||
| Q1 25 | $381.5B | $33.6B | ||
| Q4 24 | $363.3B | $33.1B | ||
| Q3 24 | $355.0B | $33.9B | ||
| Q2 24 | $332.6B | $31.9B | ||
| Q1 24 | $320.6B | $32.2B |
| Q4 25 | 0.38× | 0.96× | ||
| Q3 25 | 0.38× | 1.03× | ||
| Q2 25 | 0.43× | 1.06× | ||
| Q1 25 | 0.36× | 0.95× | ||
| Q4 24 | 0.39× | 1.06× | ||
| Q3 24 | 0.33× | 1.24× | ||
| Q2 24 | 0.38× | 1.18× | ||
| Q1 24 | 0.39× | 1.25× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.0B | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | 5.82× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0B | — | ||
| Q3 25 | $636.0M | — | ||
| Q2 25 | $1.1B | $94.0M | ||
| Q1 25 | $426.0M | $250.0M | ||
| Q4 24 | $386.0M | — | ||
| Q3 24 | $780.0M | — | ||
| Q2 24 | $525.0M | $-119.0M | ||
| Q1 24 | $185.0M | $419.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $8.0M | ||
| Q1 25 | — | $98.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-183.0M | ||
| Q1 24 | — | $274.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -3.8% | ||
| Q1 24 | — | 5.9% |
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 2.1% | ||
| Q2 25 | — | 1.7% | ||
| Q1 25 | — | 3.2% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 1.9% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | 3.1% |
| Q4 25 | 5.82× | — | ||
| Q3 25 | 0.51× | — | ||
| Q2 25 | 2.28× | 0.19× | ||
| Q1 25 | 0.92× | 0.44× | ||
| Q4 24 | 0.38× | — | ||
| Q3 24 | 1.25× | — | ||
| Q2 24 | 0.83× | -0.28× | ||
| Q1 24 | 0.16× | 1.12× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATHS
Segment breakdown not available.
GEHC
| Imaging Segment | $2.6B | 45% |
| PCS Segment | $824.0M | 14% |
| P Dx Segment | $790.0M | 14% |
| Specialized Ultrasound Subsegment | $735.0M | 13% |
| Monitoring Solutions Subsegment | $578.0M | 10% |
| Life Support Solutions Subsegment | $247.0M | 4% |
